3079 |
Role of STLS in District Review meetings |
18/08/2022 |
|
157 |
Maintaining Supplies of Lab consumables at DMC |
18/08/2022 |
|
1652 |
Root cause analysis for low performance of Percentage of Eligible Beneficiaries Paid under Ni-kshay Poshan Yojana |
18/08/2022 |
|
1648 |
Root cause analysis for low performance of Percentage of TB Notified Cases with Universal Drug Susceptibility Testing Done |
18/08/2022 |
|
1646 |
Root cause analysis for low performance of Percentage of TB Notified Patients with Known HIV Status |
18/08/2022 |
|
1656 |
Root cause analysis for low performance of Percentage Expenditure Against Approved Record of Proceedings [ROP] |
18/08/2022 |
|
1994 |
Organisational Structure of Health System |
18/08/2022 |
|
2043 |
LPA Laboratory Equipment |
29/08/2022 |
|
3108 |
Pipette |
29/08/2022 |
|
1744 |
Specimen Processing for CBNAAT |
01/09/2022 |
|
1354 |
Inbuilt Controls of CBNAAT Technology |
02/09/2022 |
|
1305 |
Troubleshooting Process for CBNAAT |
02/09/2022 |
|
1311 |
Maintenance of CBNAAT Instrument under NTEP |
02/09/2022 |
|
1696 |
Monthly Maintenance of the CBNAAT Instrument |
02/09/2022 |
|
1314 |
Monitoring of CBNAAT Quality Indicators |
02/09/2022 |
|
1367 |
PCR Amplification of the Target genes in Truenat |
02/09/2022 |
|
1292 |
Truenat MTB Assay Results Interpretation: Visualization |
02/09/2022 |
|
772 |
Pre treatment evaluation of a DRTB cases |
05/09/2022 |
|
1801 |
Laboratory Diagnosis of Drug-resistant TB |
06/09/2022 |
|
1841 |
Reliability of a Test for Diagnosis of DR-TB |
06/09/2022 |
|
3189 |
Management of DR-TB ADR |
06/09/2022 |
|
1102 |
Treatment of Drug-resistant TB |
06/09/2022 |
|
1065 |
Drug-resistant TB Service Linkages to Private Sectors |
06/09/2022 |
|
1783 |
Palliative Care in DR-TB |
06/09/2022 |
|
1569 |
Counselling during DR-TB treatment |
06/09/2022 |
|
1064 |
Weight Band-wise Dosages of DR-TB Drugs for Adults |
06/09/2022 |
|
1858 |
Key Considerations for the Use of Newer Drugs in DR-TB |
06/09/2022 |
|
630 |
DR-TB Treatment Regimens |
06/09/2022 |
|
1234 |
Longer Oral M/XDR-TB: Regimen and Duration |
06/09/2022 |
|
2620 |
Treatment of DR-TB in Children |
06/09/2022 |
|